Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis
International Journal of Molecular Sciences · 07.08.2024 · 25 (16) · 8607
DOI: 10.3390/ijms25168607 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.08.2024. Verfasst von Yasuhiko Ito und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute 480-1195, Japan. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Peritoneal Fibrosis, Peritoneum. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The characteristic feature of chronic peritoneal damage in peritoneal dialysis (PD) is a decline in ultrafiltration capacity associated with pathological fibrosis and angiogenesis. The pathogenesis of peritoneal fibrosis is attributed to bioincompatible factors of PD fluid and peritonitis. Uremia is associated with peritoneal membrane inflammation that affects fibrosis, neoangiogenesis, and baseline peritoneal membrane function. Net ultrafiltration volume is affected by capillary surface area, vasculopathy, peritoneal fibrosis, and lymphangiogenesis. Many inflammatory cytokines induce fibrogenic growth factors, with crosstalk between macrophages and fibroblasts. Transforming growth factor (TGF)-β and vascular endothelial growth factor (VEGF)-A are the key mediators of fibrosis and angiogenesis, respectively. Bioincompatible factors of PD fluid upregulate TGF-β expression by mesothelial cells that contributes to the development of fibrosis. Angiogenesis and lymphangiogenesis can progress during fibrosis via TGF-β–VEGF-A/C pathways. Complement activation occurs in fungal peritonitis and progresses insidiously during PD. Analyses of the human peritoneal membrane have clarified the mechanisms by which encapsulating peritoneal sclerosis develops. Different effects of dialysates on the peritoneal membrane were also recognized, particularly in terms of vascular damage. Understanding the pathophysiologies of the peritoneal membrane will lead to preservation of peritoneal membrane function and improvements in technical survival, mortality, and quality of life for PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute 480-1195, Japan.
- Department of Nephrology, Imaike Jin Clinic, Nagoya 464-0850, Japan.
- Department of Nephrology and Rheumatology, Aichi Medical University Medical Center, Okazaki 444-2148, Japan.
- Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
ORCID-Profile: Ting Sun, Hangsoo Kim, Takuji Ishimoto
Zitieren
APA
Ito, Y., Sun, T., Tawada, M., Kinashi, H., Yamaguchi, M., Katsuno, T., Kim, H., Mizuno, M., & Ishimoto, T. (2024). Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis. International Journal of Molecular Sciences, 25(16), 8607. https://doi.org/10.3390/ijms25168607
Vancouver
Ito Y, Sun T, Tawada M, Kinashi H, Yamaguchi M, Katsuno T, et al. Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis. International Journal of Molecular Sciences. 2024;25(16):8607. doi:10.3390/ijms25168607
BibTeX
@article{Ito2024,
author = {Ito, Yasuhiko and Sun, Ting and Tawada, Mitsuhiro and Kinashi, Hiroshi and Yamaguchi, Makoto and Katsuno, Takayuki and Kim, Hangsoo and Mizuno, Masashi and Ishimoto, Takuji},
title = {Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {16},
pages = {8607},
doi = {10.3390/ijms25168607}
}
EUVIMED